Termedia.pl
 
 
ISSN: 1505-8409
Przewodnik Lekarza/Guide for GPs
Current issue Archive About the journal Supplements Contact Instructions for authors
1/2010
vol. 13
 
Share:
Share:
more
 
 
abstract:

From the understanding of the mechanisms of inflammation in asthma to improve the formulation of inhaled drugs

Tadeusz Płusa

Przew Lek 2010; 1: 47-52
Online publish date: 2010/03/04
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Structural and functional changes in small bronchi (< 2 mm in diameter) play an important role in reducing the air flow in bronchial asthma. New techniques using gas analysis and high-resolution computed tomography shows the direction for new applications. The new formulations of inhaled β2-agonists and glucocorticosteroids in aerosols with ultra-fine particles may be more effective in controlling asthma. New combinations are more effective than previously used, because they deposit in small bronchi.
Disclosed ciclesonide rapid therapeutic effect and its formulation indicate that it can be used in asthma exacerbation, and in severe and difficult asthma, where inflammation takes place in the peripheral bronchi.
keywords:

asthma, ultra-fine particles

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe